1. Intellectual Disability: Diagnosis and Genetic Causes
Defines intellectual disability, explains the importance of diagnosis, and describes its potential causes including genetic abnormalities. Introduces high-throughput sequencing and how discovering genetic anomalies helps families and advances medicine.
intellectual disability and scientific research from diagnosis to
treatment why and how do we search for the origin of intellectual disability
intellectual disability or mental handicap is a neurodevelopmental disorder characterized by impaired cognitive function and adaptive behavior to complex or new situations it affects language and logical reasoning over a continuum of severity ranging from mild to severe it canbe diagnosed at different stages of development at birth in early childhood or later when the child starts struggling at school establishing an accurate diagnosis for the disease is one of the most important issues for patients and their familiesa diagnosis makes it possible to understand the origin of disorder the disease itself and its progression and adapt to medical follow-up and education families can also attend genetic counseling and learn about the possible risks of transmission intellectual disabilityhas many potential causes which explains the great heterogeneity in type and severity these causes may be related to events that occur during brain development including infection intoxication trauma or lack of oxygen or they can be the result of
a genetic abnormality that alters how the brain structures itself from the time the embryo is conceived in as much as 50 of cases we still do not know the underlying reasons for the intellectual disability it is estimated thatmore than half of undiagnosed situations are due to unidentified genetic abnormalities scientific research makes it possible to discover new genes involved in intellectual disability every year reducing the diagnostic odyssey of patients is only possible through scientific progress andimproved access to specialized consultations and examinations
from the moment the embryo is conceived our body develops from a unique genetic program encoded by the genes contained in our chromosomes genes are composed of a succession of codes that allow the production of molecules necessary for thegrowth and proper functioning of the body variations in this code exist in all individuals most of them are harmless but some severely disrupt the development and functioning of the brain and can lead to intellectual disabilityhigh throughput sequencing is a technology that allows the identification of genetic variations the difficulty residing in analyzing and interpreting these large data sets to establish a link between the variations seen in a gene and the disease the discoveryof a genetic anomaly is an important step for families generally it does not lead to major changes in existent support but it does make it possible to adapt the support plan and to provide specific medical follow-up this is
the case for a number of syndromes that are now well described and for which there are specific care recommendations providing a real improvement in patient health and quality of life each patient thus contributes to a better knowledge ofthe disease and its effects and can help to advance medicine
2. How Genetic Abnormalities Affect Brain Development
Explains the three main types of disturbances caused by genetic abnormalities: brain malformations, metabolic disruptions, and impaired brain plasticity. Describes associated disorders and how research is opening new therapeutic approaches.
what is the link between genetic abnormality development and brain function from the embryonic stage to adulthood genetic abnormalities modify the development and functioning of the brain in several ways depending on the function of the genes involved they causethree main types of disturbances brain malformations affecting the structure of the brain disruptions in cellular metabolism with anomalies in the manufacturing and regulation of molecules essential to the body abnormalities affecting the ability of neurons the main brain cellpopulations transporting information to connect to each other which is defined as brain plasticity
an example is a significant decrease in the size of the brain this is called microcephaly which restricts the development of neurons or on the contrary the brain can be abnormally large this is called macrocephaly which is linked toother neurological anomaliessmaller finer changes in brain architecture are also implicated in such cases one or several brain nuclei or structures amongst hundreds are affected during development and end up missing or being poorly developed examples include the following a defect inthe formation of gray matter due to poor migration of neurons to the cerebral cortex which can lead to an absence of folds on the surface of the brain known as licincephalya malformation of the cerebellum
an anomaly in the connection between the different areas of the brain with a defect in the constitution of the white matter such as in a genesis of the corpus callosum a condition characterized by the absence of the corpuscallosum the largest white matter structure of the brain
genetic defects can also disrupt neuronal metabolism and lead to insufficient transport of necessary substances inside the cells inadequate protein formation lack of energetic substrates for the cell accumulation of toxic substances
in some cases damage does not affect the structure of metabolism of the brain but its plasticity brain plasticity is essential to acquire new skills through the many connections between neurons as we experience and are stimulated by the environmentwhen cerebral plasticity is impaired brain functions are restricted ultimately resulting in altered information processing inappropriate emotions and language difficulties making it impossible for a person to adapt to the environment simultaneously the brain becomes more excitable while less ableto filter information and to protect itself from sensory stimuli and strong emotions
abnormal brain development regardless of its origin can lead to a spectrum of intellectual disability that is often accompanied by specific identifiable disorders language disorders learning delays emotional control difficulties etc abnormal brain development can cause other disorders intellectual disabilitycan be accompanied for example by a motor disorder epilepsy behavioral disorders sleep disorders or eating disorders in addition a genetic defect may not be limited to neuronal cells other cells and organs may also be affected by its variationthe well-described genetic diseases are often characterized by symptoms that make the diagnosis likely and ensure specific medical follow-up for this reason recommendations are very important of course even with the same genetic disease every case is unique scientific researchis increasingly shedding light on the complex genetic and biological processes of brain development and function at the same time neuroscience research is opening up new areas of explorationall these advances are making it possible to design new cutting-edge therapeutic approaches
3. Treatments and Therapeutic Research Approaches
Covers current therapeutic options including gene therapy, metabolic treatments, and precision medicine, along with non-drug approaches like cognitive remediation. Highlights challenges in clinical trials for neurodevelopmental conditions.
what treatments are possible and what research is being donetoday we do not know how to cure intellectual disability yet nevertheless therapeutic approaches can improve the development of cognitive and adaptative skills treat disorders and symptoms and improve overall quality of life while it is still very difficult toact directly on the genetic anomaly and the cellular mechanisms involved scientific knowledge has led to new therapeutic avenues
gene therapy consists in using a virus to introduce a gene fragment into the cell this gene fragment is designed to replace the defective gene and correct the genome however the brain cells neurons are very difficult to reach becausethey are carefully protected and lie inside the skull gene therapy is therefore not yet an accessible therapy for neurodevelopmental conditions and is only being tested in a few isolated cases
for several genetic diseases that affect the cell's metabolism there are specific treatments that can improve or restore cell metabolism such treatments include a diet low on certain amino acids or ketogenic diets rich in fat with non-synthetized vitamins suchas biotin or thiamine or by providing a missing enzyme with enzyme therapy early diagnosis and treatment of the disease are therefore essential to limit its
impact for other diseases it is known that the defective gene has a cascading effect on brain activity with a disruption of the molecular pathways involvedfor example in bourneville syndrome which often includes intellectual disability severe epilepsy as well as affects many organs it is now known as a disorder of the mtor molecular pathway involved in the onset of symptoms several drugs blocking themtor pathway have been developed and have shown their ability to improve certain symptomsanother example is fragile x syndrome in which there is a disruption of the gaba and glutamine molecular pathways which are important for the communication between neurons this disruption explains many of the symptoms of fragile x anxiety hypersensitivity hyperactivityand epileptic seizures many studies have considered therapeutic approaches for fragile x syndrome with many drugs being tested but overall none have been effective this shows the great difficulty associated with clinical trials in the field of neurodevelopment
in all cases therapy aims to limit disease progression and treat as many symptoms as possible depending on the individual situation tailored drug treatments also called precision medicine and non-drug approaches can be recommended it is important to note thatbecause people with intellectual disabilities have difficulty expressing themselves the interpretation of symptoms is complex for example an abnormal behavior should not systematically be qualified as a psychiatric disorder because it may reveal undetected pain a complete medical examination mustbe carried out with the prescription of an appropriate treatment necessary the drugs that are used are those usually prescribed tailoring them to the individual's particular situation and to what is known about the genetic disease orsyndrome in addition drug-free measures can be offered to the patients from an early age and throughout life to help the person live a better life it may be one or a combination of rehabilitation measures personalized educational support more
recently developed cognitive remediation programs
in cognitive remediation therapy an objective has to be defined for each measure of support the therapist will help the person to mobilize their preserved capacities and to develop specific strategies that will allow them to bypass limitations and interactwith the environment in a more appropriate way current research focuses heavily on the development of programs for learning disabilities lack of independence behavioral disorders or social adjustment difficulties by better understanding the cognitive and behavioral profiles of each syndromeneuropsychology makes it possible to improve therapeutic support these non-drug approaches are not a cure but they aim to improve quality of life and to support each patient's personal goals today's therapeutic strategies use the most recent knowledge in allfields neurodevelopment genetics pharmacology neuroscience educational sciences together let's make scientific progress
4. Clinical Research: From Molecule to Medicine
Walks through the drug development process from molecule identification and pre-clinical testing to the four phases of clinical trials. Explains randomization, double-blinding, marketing authorization, and post-market phase 4 studies.
clinical research from molecule to medicine
thousands of molecules are studied in a therapeutic objective all of them will not pass the different tests only one will become a drug here is its story first we need to identify the molecules of interest it starts withthe understanding of the disease its clinical and biological signs and also the mechanisms by which a drug could reset normal function of the organism with this knowledge the researcher thinks of some molecules that could be activeonce synthesized these molecules go to the pre-clinical phase after performing different tests at the laboratory and before turning to human beings it is necessary to test the molecules on animals these tests bring useful knowledge for the future drugespecially about its toxicity we are trying to find what is called the non-toxic maximum dose it is not possible to test directly on human beings at the end of the pre-clinical studies the researcher has an idea of the
dose he can use on humans all studies performed on humans must be authorized and be done with the patient's agreement after full information voluntary participants will sign an informed consent form it is the participant who decides if hewishes to participate or not a first phase called phase one is then performed in a small number of healthy volunteers it is the first administration on humans we are checking if the drug is safe to use we arealso interested on how the drug acts on the body it is called pharmacokinetics phase 1 always starts with one patient alone who receives only one dose of the drug then we look at the safety and if everything isfine we can give the drug to another patient and so on then in different doses experts decide if it's okay if there is a safety issue everything can be stopped then phase two can start in the second phase
we are trying to determine the optimal dose of the drug the one that seems the most efficacious with the least side effects we are trying to establish a relationship between the dose and the effect of the drug severaldoses are tested and compared at the end of this phase we have defined the dose that will eventually be used
in phase 3 we test the dose determined in the previous phase phase 3 is the phase where we want to test the efficacy of the drug we often speak about randomized double-blind controlled trial versus placebo to demonstrate theefficacy of a new treatment or therapy we must compare and show that patients who take the treatment or therapy are doing better than those who don't take it we talk about a controlled trial we use a placebo aproduct which does not contain any active principle the placebo must look exactly like the study treatment we must not be able to differentiate the placebo from the active drug to demonstrate the efficacy of the drug our two groupsof patients study drug versus placebo must be comparable to get comparable groups we randomize which means that we assign by chance one patient to one of the groups randomization equally distributes patients with specific characteristics in each group groups
are thus comparable to be sure that the patients receiving the placebo or the study drug are followed up equally during the trial we use double blinding neither the doctor nor the patient know if they are receiving the placeboor the study drug randomization and double blinding are methods that avoid what we call biases elements which can influence the measurement and the efficacy and lead to a wrong result finally it is a marketing authorization
at the end of phase three if everything went well a marketing authorization ma can be requested any time during the development of a medicine everything can be stopped because of safety issues or the unefficiency of the drug allmolecules tested will not become a medicine lots of molecules don't make it and fail results of pre-clinical and clinical studies decide of the success of a moleculeafter marketing authorization it is not finished for our medicine it enters real life other studies can be conducted they are called phase 4 studies they allow a better understanding of the medicine in real life conditions for instance abetter understanding of the safety of the medicine phase 4 clinical trials can be conducted to verify that under real life use and in bigger size population the medicine does not have other side effects for example not yet seenduring clinical trials this is why sometimes medicine can be retrieved from the market after a certain time in use